Sanofi Consumer Healthcare India Limited — Important, 10-04-2025: General Updates

The Committee of Independent Directors at Sanofi Consumer Healthcare India Limited has provided its written recommendations regarding the open offer from Opal Bidco SAS and Clayton, Dubilier & Rice Fund XII, L.P. This offer seeks to acquire up to 59,87,962 fully paid-up equity shares, which represent 26% of the company's fully diluted voting share capital, at an offer price of ₹4,982.05 per share. The recommendations will be published in major newspapers, ensuring transparency for shareholders. This strategic move indicates a potential shift in ownership dynamics, which shareholders should monitor closely for its implications on company operations and market positioning.